Sugi Predict

Sugi Predict / Compounds / SCHEMBL1766035

SCHEMBL1766035

SCHEMBL1766035

c1ccc(-c2nc3c(-c4ccccc4)ccc(-c4ccccc4)c3nc2-c2ccccc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DHFR P00374 1/20 0.47
▸ PIK3CG P48736 1/20 0.47
▸ LMNA P02545 5/20 0.46
▸ L3MBTL1 Q9Y468 4/20 0.46
▸ MEN1 O00255 4/20 0.46
▸ KMT2A Q03164 4/20 0.46
▸ TDP1 Q9NUW8 3/20 0.46
▸ HTT P42858 2/20 0.46
▸ TP53 P04637 2/20 0.46
▸ MAPK1 P28482 2/20 0.46
▸ ADORA2A P29274 1/20 0.45
▸ ADORA1 P30542 1/20 0.45
▸ KDM4E B2RXH2 7/20 0.43
▸ GAA P10253 4/20 0.43
▸ ALDH1A1 P00352 8/20 0.43
▸ HPGD P15428 3/20 0.43
▸ TSHR P16473 2/20 0.43
▸ HSD17B10 Q99714 2/20 0.43
▸ ALOX15 P16050 1/20 0.42
▸ MAPT P10636 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13078995 0.95 L3MBTL1 (0.45) DHFRPIK3CGLMNAL3MBTL1MEN1
SCHEMBL13078982 0.95 L3MBTL1 (0.45) DHFRPIK3CGLMNAL3MBTL1MEN1
SCHEMBL13078939 0.95 L3MBTL1 (0.45) DHFRPIK3CGLMNAL3MBTL1MEN1
SCHEMBL13078994 0.95 L3MBTL1 (0.45) DHFRPIK3CGLMNAL3MBTL1MEN1
SCHEMBL13078969 0.91 L3MBTL1 (0.47) DHFRPIK3CGLMNAL3MBTL1MEN1
SCHEMBL13079002 0.91 L3MBTL1 (0.43) DHFRPIK3CGLMNAL3MBTL1MEN1
SCHEMBL4941504 0.89 L3MBTL1 (0.44) DHFRPIK3CGLMNAL3MBTL1MEN1
SCHEMBL13078961 0.88 ALDH1A1 (0.40) DHFRPIK3CGLMNAL3MBTL1MEN1
SCHEMBL13078977 0.88 KDM4E (0.40) DHFRPIK3CGLMNAL3MBTL1MEN1
SCHEMBL13181613 0.87 ALDH1A1 (0.44) L3MBTL1MEN1KMT2AMAPK1ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 132 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118027030-A Preparation method of nitrogen-containing heterocyclic ring organic electronic transmission material 山东千铄新材料有限公司 2024-05-14 — — CN disclosed
CN-116925073-A Nitrogen-containing heterocyclic ring organic electronic transmission material, preparation method and application 山东千铄新材料有限公司 2023-10-24 — — CN disclosed
CN-111484468-B Compound for preparing organic photoelectric device 烟台显华光电材料研究院有限公司 2023-09-22 — — CN disclosed
CN-111434648-B Compound for manufacturing organic electroluminescent device and application thereof 烟台显华化工科技有限公司 2023-09-12 — — CN disclosed
CN-111349055-B Polycyclic compound used as electroluminescent material and application thereof 烟台显华光电材料研究院有限公司 2023-04-21 — — CN disclosed
CN-111362978-B Boron-nitrogen heteroaromatic compound used as blue fluorescent material and application thereof 烟台显华化工科技有限公司 2023-04-07 — — CN disclosed
CN-111333681-B Transition metal complex used as phosphorescent material and application thereof 烟台显华光电材料研究院有限公司 2023-04-07 — — CN disclosed
CN-111039985-B Transition metal complex used as phosphorescent material and application thereof 烟台显华光电材料研究院有限公司 2022-08-02 — — CN disclosed
CN-113185517-A Aza-aromatic compound used as blue fluorescent material and application thereof 烟台显华化工科技有限公司 2021-07-30 — — CN disclosed
CN-109111455-B Iridium complex used as phosphorescent material, preparation method and application thereof 烟台显华光电材料研究院有限公司 2020-10-09 — — CN disclosed
EP-2075860-A2 Light-emitting element, light-emitting device and electronic device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2009-07-01 — — EP disclosed
EP-2075860-A2 Light-emitting element, light-emitting device and electronic device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2009-07-01 — — EP disclosed
US-20080217608-A1 Light-Emitting Element, Light-Emitting Device, Electronic Device and Quinoxaline Derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2008-09-11 — — US disclosed
US-20080217608-A1 Light-Emitting Element, Light-Emitting Device, Electronic Device and Quinoxaline Derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2008-09-11 — — US disclosed
US-20080217608-A1 Light-Emitting Element, Light-Emitting Device, Electronic Device and Quinoxaline Derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2008-09-11 — — US disclosed
WO-2008102713-A1 LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE AND QUINOXALINE DERIVATIVE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2008-08-28 — — WO disclosed
WO-2008102713-A1 LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE AND QUINOXALINE DERIVATIVE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2008-08-28 — — WO disclosed
US-20080193794-A1 Quinoxaline Derivative, Light-Emitting Element, Light-Emitting Device, and Electronic Appliance SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2008-08-14 — — US disclosed
US-20080193794-A1 Quinoxaline Derivative, Light-Emitting Element, Light-Emitting Device, and Electronic Appliance SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2008-08-14 — — US disclosed
US-20080193794-A1 Quinoxaline Derivative, Light-Emitting Element, Light-Emitting Device, and Electronic Appliance SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2008-08-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080193794-A1 Quinoxaline Derivative, Light-Emitting Element, Light-Emitting Device, and Electronic Appliance SLC35E1, SLC1A2, ATP1A2 DHFR 3454/4885PIK3CG 4766/4885LMNA 3919/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.